T-Ray Science, Inc. brings together a team of high-level academic researchers, pharmaceutical industry experts, medical device industry experts, and corporate finance professionals to execute a targeted product strategy.

In 2008, the Company filed five patents, including a patent on the world’s first continuous-wave (CW) terahertz spectrometer.  The Company also signed an exclusive license agreement with MIT on what is believed to be the best method of creating CW THz waves.  T-Ray is using this technology to develop our own THz skin cancer imager and is offering sublicense agreements to Companies developing applications using continuous wave technology.